Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depo-Medrol and lidocaine injection for carpal tunnel syndrome
NL-OMON40966Withdrawn
- Sponsor
- HagaZiekenhuis
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylprednisolone and lidocaine in carpal tunnel syndrome (CTS) and median neuropathy, sponsored by HagaZiekenhuis. Primary endpoint: Clinical and neurophysiological changes of the median nerve after injection. Planned start May 2014; status: withdrawn.
02
Drugs
methylprednisolonelidocaine
03
Conditions
carpal tunnel syndrome (CTS)median neuropathy
Beyond the preview
Go deeper on NL-OMON40966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40966.